Abstract:Objective To investigate the changes and significance of serum ADAM33 and S1P in asthma patients. Methods Selected 120 patients with acute asthma (asthma group) and 60 healthy subjects (control group) were enrolled in our hospital from January 2015 to December 2017. The levels of ADAM33 and S1P in the serum of the two groups were measured, and stratified analysis was performed according to the condition of asthma; the relationships between the levels of ADAM33, S1P in serum and EOS, IgE, FEV1%, PEF% of patients were analyzed. Results The levels of ADAM33 and S1P in the asthma group were higher than in the control group (P?0.05); the serum levels of ADAM33 and S1P in the severe asthma group were higher than those in the mild-to-moderate group (P?0.05); the levels of peripheral blood EOS and IgE in the asthma group were higher than those in the control group, and the difference between the two groups was statistically significant (P?0.05); the FEV1% and PEF% of the asthma group were lower than the control group (r?=?0.629 and 0.572, P?=?0.000); serum S1P and ADAM33 in the asthma group were negatively correlated with FEV1% and PEF% (r?=?-0.382, -0.411, -0.574 and -0.494, respectively, all P?=?0.000). Conclusions Serum levels of S1P and ADAM33 in patients with acute asthma increase, which is related to lung function and the degree of asthma attack.